Immune Regulation Insights from RaFJC Conference – Reproduction and Fertility
Reproduction and Fertility shared a post on LinkedIn:
“Day 5 and the final day of RaFJC – Immune Regulation Across Reproduction: From Mechanisms to Therapies
Over the past five days, we’ve explored the immune and inflammatory continuum in reproduction:
During Day 1, we discussed ovulation as an immune-regulated event, with extracellular matrix and cytokine pathways shaping follicle rupture.
On Day 2, we discussed implantation as a form of controlled inflammation that balances tolerance and defense.
On Day 3, we explored how early-pregnancy immune markers (NK CD69, CD57) may predict viability in ART patients.
On Day 4, we theorised about an innovative translational therapy: placenta-targeted nanoparticles for localised immune cloaking in recurrent pregnancy loss.
Today, we synthesise these insights to highlight future directions in reproductive immunology.
Immune balance is central: too much inflammation leads to implantation failure, while too little results in poor tissue remodeling.
Peripheral biomarkers matter: blood-based immune signatures may offer early diagnostic tools for pregnancy outcomes.
Targeted therapies are the future: moving away from systemic immunosuppression toward site-specific immune modulation (e.g., nanoparticles, ligand-based cloaking).
Cost and scalability: innovative therapies must be affordable and manufacturable at scale to reach patients globally.
Immune pathways guide reproduction from ovulation to delivery.
By integrating basic science, clinical diagnostics, and translational therapies, we can:
- improve fertility treatments
- reduce miscarriage rates
- enhance maternal and fetal health outcomes
This continuum underscores the importance of multidisciplinary collaboration between immunologists, clinicians, and translational researchers.
Share your opinion:
- Which biomarkers should be prioritized for clinical validation?
- How can we ensure equitable access to emerging therapies?
- Which collaborations are needed to accelerate translation from the lab to the clinic?”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 15, 2026, 11:37Ally Murji: Honoured to be Part of the Canadian Session at the SEUD Meeting
-
Apr 15, 2026, 11:00Scammers are Targeting ESHRE2026 Attendees With Fake Registration and Hotel Offers – ESHRE
-
Apr 15, 2026, 10:24Join Us This Friday for Our “Research in Progress” – SRF
-
Apr 15, 2026, 10:20The Importance of Fertility Preservation in Turner Syndrome – RBMO
-
Apr 15, 2026, 10:16Marlena Fejzo: Our Study Identifying 6 New Genes Associated with Hyperemesis Gravidarum
-
Apr 15, 2026, 10:07Applications Are Open for the 2027 Cohort of the ASRM/SRBT CELL Program – ASRM
-
Apr 14, 2026, 15:14This Month’s F and S On Air Podcast Is Out Now – Fertility and Sterility
-
Apr 14, 2026, 14:51Lydia Akpan: Key Signs of Oocyte Dysmorphism
-
Apr 14, 2026, 14:42Emre Göksan Pabuçcu: Honored to Speak at the 12th National Gynecological Endoscopy Congress